Pathological responses to neoadjuvant immunochemotherapy: implications for survival and recurrence in patients with locally advanced esophageal squamous cell carcinoma
PTs response may constitute a more prominent determinant of both OS and PFS than LNs status, and combining these factors enhances prognostic prediction.
Authors
- Yong Sang Hong (ORCID: https://orcid.org/0000-0001-5672-0072)
- Ming Jiang (ORCID: https://orcid.org/0000-0002-8935-3886)
- Yinan Wu
- Jianyin Zhou (ORCID: https://orcid.org/0000-0002-4396-4518)
- Yu Chen (ORCID: https://orcid.org/0000-0002-8206-3325)
- Yixin Li (ORCID: https://orcid.org/0000-0001-8740-5040)
- Yang Zhao (ORCID: https://orcid.org/0000-0001-9318-5371)
- Xiangzhi Zhu
- Gang Xiao (ORCID: https://orcid.org/0000-0003-0299-5681)
- Bo Yang (ORCID: https://orcid.org/0000-0002-1748-9514)
- Ning Jiang (ORCID: https://orcid.org/0000-0001-7697-5152)
- Xiaochen Huang (ORCID: https://orcid.org/0000-0002-5473-7222)
- Qiang‐Wu Tan (ORCID: https://orcid.org/0009-0009-4953-199X)
- Lingling Gu
- Zihao Zhu
- Youtao Xu (ORCID: https://orcid.org/0000-0002-6999-4870)
Institutions
- Jiangsu Cancer Hospital (CN)
- Nanjing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1186/s12967-025-07158-y
- Citations
- 2
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Government of Jiangsu Province
- Wu Jieping Medical Foundation
- Jiangsu Cancer Hospital